Clinical Trials Directory

Trials / Conditions / Advanced Parkinson's Disease

Advanced Parkinson's Disease

19 registered clinical trials studyying Advanced Parkinson's Disease — 2 currently recruiting.

StatusTrialSponsorPhase
RecruitingSAD Study in Patients With Parkinson's Disease and Motor Fluctuations
NCT07422675
Serina TherapeuticsPhase 1
RecruitingA Study to Assess Change in Sleep Disturbances of Adult Participants With Advanced Parkinson's Disease Receivi
NCT07284342
AbbVie—
Active Not RecruitingAn Automated Navigation System for Deep Brain Electrode Implantation
NCT06396494
Beijing Tiantan Hospital—
UnknownA Study on the Safety and Tolerability of RGL-193 in Patients With Advanced Parkinson's Disease
NCT06195124
Second Affiliated Hospital of Soochow UniversityEARLY_Phase 1
CompletedPhase 1 Safety and Tolerability Study of MSK-DA01 Cell Therapy for Advanced Parkinson's Disease
NCT04802733
BlueRock TherapeuticsPhase 1
CompletedA Study to Assess the PK and Pharmacodynamics of IPX203 in Subjects With Advanced Parkinson's Disease
NCT03007888
Impax Laboratories, LLCPhase 2
CompletedObservational Study Evaluating Long-Term Effectiveness of Duodopa/Duopa in Patients With Advanced Parkinson's
NCT02611713
AbbVie—
CompletedA Study to Examine the Effect of Levodopa-Carbidopa Intestinal Gel (LCIG) Therapy Relative to That of Optimize
NCT02549092
AbbViePhase 3
CompletedAn Extension Study to Assess the Safety, Tolerability and Efficacy of ABT-SLV187 in Subjects With Advanced Par
NCT02082249
AbbViePhase 3
CompletedA Study to Assess the Efficacy, Safety and Tolerability of ABT-SLV187 Monotherapy in Subjects With Advanced Pa
NCT01960842
AbbViePhase 3
UnknownClinical Study for Adaptive Deep Brain Stimulation (aDBS)Controlled by Intracerebral Activity in Parkinson's D
NCT02154724
Fondazione IRCCS Ca' Granda, Ospedale Maggiore PoliclinicoN/A
CompletedA Study to Assess the Safety and Efficacy of Levodopa-carbidopa Intestinal Gel (LCIG) for the Treatment of Non
NCT01736176
AbbVie (prior sponsor, Abbott)Phase 3
CompletedA Phase 3b, Open-Label, Safety and Efficacy Study of Rotigotine as Add-On Therapy With Low Doses of Pramipexol
NCT01723904
UCB BIOSCIENCES GmbHPhase 3
TerminatedEffect of Rotigotine on Motor Symptoms in Patients With Advanced Parkinson's Disease (PD) With Motor Fluctuati
NCT01536015
UCB PharmaPhase 3
CompletedStudy of Safety, Tolerability, Pharmacokinetics, and Efficacy of ABT-SLV187 in Subjects With Advanced Parkinso
NCT01479127
AbbVie (prior sponsor, Abbott)Phase 2
CompletedStudy of Efficacy, Safety and Tolerability of Levodopa-Carbidopa Intestinal Gel in Levodopa-Responsive Parkins
NCT00660387
AbbVie (prior sponsor, Abbott)Phase 3
CompletedOpen Label Continuation Treatment Study With Levodopa-Carbidopa Intestinal Gel in Advanced Parkinson's Disease
NCT00660673
AbbViePhase 3
CompletedStudy of Efficacy, Safety and Tolerability of Levodopa-Carbidopa Intestinal Gel in Levodopa-Responsive Parkins
NCT00357994
AbbVie (prior sponsor, Abbott)Phase 3
CompletedLevodopa-Carbidopa Intestinal Gel Open-Label Study in Advanced Parkinson's Disease
NCT00335153
AbbVie (prior sponsor, Abbott)Phase 3